Barclays has initiated coverage on Boeing with an Overweight rating, expecting it to outperform peers despite challenges like high debt, production delays, and order cancellations. Boeing's stock has recently declined more than its aerospace-defense peers due to these company-specific issues. However, significant defense contracts, including a $14.7 billion award from Lockheed Martin, and a discounted valuation provide potential growth catalysts. Analysts see value in Boeing's stock, trading at a notable discount to estimated worth, suggesting upside potential for investors.
Boeing's market cap stands at $148.39 billion with a modest dividend yield of 0.03%, reflecting its scale despite industry challenges. On Pluang, Boeing shares trade at USD 188.17, showing a slight 0.22% increase as of Oct 09, 2026 19:51 WIB, with strong buyer interest at 85% of order activity. This contrasts with Lockheed Martin, which has a market cap of $117.22 billion and a higher dividend yield of 2.72%, trading slightly down by 0.27% on the same platform and time.
Boeing secured a $20 billion Navy fighter development contract and a $14.7 billion missile seeker deal in one week, alongside an FAA clearance on a MAX software issue and a labor contract approval. Despite these wins, Boeing's stock trades at $192.74...
Boeing received a $14.7 billion contract from Lockheed Martin to triple production of PAC-3 Missile Segment Enhancement seekers over seven years. This increase supports the U.S. Department of War's strategy to enhance national defense capabilities by...
